Shanghai Humantech Biotechnology Co. Ltd
1 clinical trials · Sponsor
◉ Watch Shanghai Humantech Biotechnology Co. Ltd
| Record | Firm | Date |
|---|---|---|
| Safety of Prodencel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC) (NCT05533203) | Shanghai Humantech Biotechnology Co. Ltd | 2022-08-08 |
Track Shanghai Humantech Biotechnology Co. Ltd automatically
Every clearance here is in the API, with alerts when new ones post.